Chakma Justin's Form 4 filing
ARS Pharmaceuticals, Inc. (SPRY) · filed Dec 6, 2024
- Accession no.
- 0001415889-24-028567
- Filed
- Dec 6, 2024
- Trade date
- Dec 4-6, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.04M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chakma JustinCIK 0001951238 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2024 | Common Stock | MOption exerciseAcquired | +45,000 | $0.84 | +$37,800 | 181,380 | Direct | |
| Dec 4, 2024 | Common Stock | SSaleDisposed | −45,000 | $13.95 | −$627,750 | 136,380 | Direct | |
| Dec 5, 2024 | Common Stock | MOption exerciseAcquired | +49,640 | $0.84 | +$41,697.6 | 186,020 | Direct | |
| Dec 5, 2024 | Common Stock | SSaleDisposed | −49,640 | $14.13 | −$701,413.2 | 136,380 | Direct | |
| Dec 6, 2024 | Common Stock | MOption exerciseAcquired | +50,000 | $0.84 | +$42,000 | 186,380 | Direct | |
| Dec 6, 2024 | Common Stock | SSaleDisposed | −50,000 | $14.23 | −$711,500 | 136,380 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2024 | Common Stock | MOption exerciseDisposed | −45,000 | $0.00 | $0 | 149,640 | Direct | |
| Dec 5, 2024 | Common Stock | MOption exerciseDisposed | −49,640 | $0.00 | $0 | 100,000 | Direct | |
| Dec 6, 2024 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 50,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.